Yanli Hao
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
Papers in
-
- RNA Interference and Gene Delivery 11
- Advanced biosensing and bioanalysis techniques 8
- Cancer therapeutics and mechanisms 4
-
- Nanoparticle-Based Drug Delivery 9
- Co-authors
- Xiaoning Zhang (9 shared papers)Sheng Luan (1 shared paper)Veder J. Garcia (1 shared paper)Legong Li (1 shared paper)Congcong Hou (1 shared paper)Wang Tian (1 shared paper)Kai He (1 shared paper)Thomas J. Kleist (1 shared paper)
- Journals
- International Journal of Nanomedicine (3 papers)Scientific Reports (2 papers)Journal of Biomedical Nanotechnology (2 papers)Journal of Minimally Invasive Gynecology (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Yanli Hao
39 papers receiving 939 citations
Peers
Comparison fields: 5 of 120
- Biomaterials 293
- Pharmaceutical Science 69
- Obstetrics and Gynecology 81
- Reproductive Medicine 79
- Molecular Biology 402
Countries citing papers authored by Yanli Hao
This map shows the geographic impact of Yanli Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Hao more than expected).
Fields of papers citing papers by Yanli Hao
This network shows the impact of papers produced by Yanli Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Hao. The network helps show where Yanli Hao may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanli Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 178 | |
| 2 | 2013 | 101 | |
| 3 | 2006 | 96 | |
| 4 | 2018 | 74 | |
| 5 | 2011 | 48 | |
| 6 | 2017 | 39 | |
| 7 | 2008 | 38 | |
| 8 | 2015 | 34 | |
| 9 | 2013 | 27 | |
| 10 | 2005 | 26 | |
| 11 | 2018 | 22 | |
| 12 | 2012 | 19 | |
| 13 | 2015 | 19 | |
| 14 | 2019 | 18 | |
| 15 | 2018 | 17 | |
| 16 | 2005 | 15 | |
| 17 | 2018 | 15 | |
| 18 | 2016 | 15 | |
| 19 | 2021 | 14 | |
| 20 | 2018 | 13 |
About Yanli Hao
Yanli Hao is a scholar working on Molecular Biology, Biomaterials, Oncology, Obstetrics and Gynecology and Reproductive Medicine, having authored 40 papers that have together received 949 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (11 papers), Nanoparticle-Based Drug Delivery (9 papers), Advanced biosensing and bioanalysis techniques (8 papers), Drug Transport and Resistance Mechanisms (5 papers), Uterine Myomas and Treatments (5 papers), Cancer therapeutics and mechanisms (4 papers), Endometriosis Research and Treatment (4 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Biomaterials (293 citations), Pharmaceutical Science (69 citations), Obstetrics and Gynecology (81 citations), Reproductive Medicine (79 citations) and Molecular Biology (402 citations). Yanli Hao has collaborated with scholars based in China and United States. Frequent co-authors include Xiaoning Zhang, Sheng Luan, Veder J. Garcia, Legong Li, Congcong Hou, Wang Tian, Kai He, Thomas J. Kleist, Nan Liu and Jun Li. Their work appears in journals such as International Journal of Nanomedicine, Scientific Reports, Journal of Biomedical Nanotechnology, Journal of Minimally Invasive Gynecology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.